MR continues to advance during a year of adversity
As we come to the end of 2021 – another year marked by the COVID-19 pandemic – many of us will have the opportunity to travel to Chicago for the Radiological Society of North America (RSNA) annual scientific sessions. Many meetings in the last year were cancelled or moved to a virtual environment due to the virus and travel restrictions, but that is starting to change. While smaller meetings may benefit from an online or web-based approach, I do believe getting together face-to-face and networking with our colleagues is one of the most important aspects of these assemblies. I am personally ready to return to in-person meetings.
News

A special welcome to our 2021 guest editor

New GE editorial board members

MR useful in evaluating heart health of athletes who have recovered from COVID-19

New study to investigate neurological and neuropsychiatric impact of COVID-19

NIH launches COVID-19 Neuro Databank/Biobank

Thorax MR supports COVID-19 diagnosis and follow-up

FDA approves first PSMA-targeted PET imaging radiotracer for men with prostate cancer

PET/MR biomarkers guide personalized treatment for patients with pancreatic cancer

Whole-body MR imaging might detect myeloma earlier
Spotlight

Intelligently efficient deep-learning reconstruction in MR

AIR Recon DL for consistent image quality and exam time reduction

Addressing the challenges of SNR and respiratory motion in body MR

Deep-learning technology delivers shorter exam times and better image quality

Leveling up image quality for confidence in cancer care

Clinical applications of MR with AIR Recon DL and HyperSense

DL-based reconstruction abstracts to be presented at ISMRM 2021
In Practice

Advanced neuroimaging at Hull gets a big lift

Quantitative analysis of multiparametric MR to detect early signs of liver disease

PET/MR delivers precision for differential diagnoses in neuroimaging

Combined PET/MR imaging in suspected CTE patients
Case Studies

Consistent slice prescription in irregular brain morphology and follow-up exams

T2 FLAIR Cube for diagnosing Ménière’s disease

Comprehensive evaluation of papilledema
Tech Trends

AIR Recon DL from proof-of- concept to clinical product

Quantitative susceptibility mapping at 7.0T

Using DL to plan a scan with fewer clicks and more consistent results